A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics

Published:2022-08-03 Issue:8 Volume:15 Page:945-958
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Wattanakul Thanaporn¹^ORCID,Chotsiri Palang¹^ORCID,Scandale Ivan²^ORCID,Hoglund Richard M.¹³^ORCID,Tarning Joel¹³^ORCID

Affiliation:

1. Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

2. Drugs for Neglected Diseases Initiative, Geneva, Switzerland

3. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Funder

Wellcome Trust

Bill and Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2113388

Reference80 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs

2. A review on drug repurposing applicable to COVID-19

3. Network-Based Methods for Prediction of Drug-Target Interactions

4. The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.

5. Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteers

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nipah virus disease: what can we do to improve patient care?;The Lancet Infectious Diseases;2024-07

2. How health technology assessment can help to address challenges in drug repurposing: a conceptual framework;Drug Discovery Today;2024-06

3. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

4. Repurposing of Chemotherapeutics to Combat COVID-19;Current Topics in Medicinal Chemistry;2022-12

5. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19;Microorganisms;2022-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3